Safety, Efficacy, And Pharmacodynamic (Pd) Activity Of 12 Weeks Treatment With Oral Rig-I Agonist, Inarigivir (Irig), Plus 48 Weeks Of Tenofovir Alafenamide In Adult Patients With Chronic Hepatitis B: A Phase 2 Collaboration Study
JOURNAL OF HEPATOLOGY(2021)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要